Can an AI eye guide surgeons to safer, faster cancer removal?

NCT ID NCT07757906

First seen Aug 11, 2026 · Last updated Aug 12, 2026 · Updated 1 time

Summary

This trial tests an artificial intelligence system called ADTPS that helps doctors remove early-stage esophageal cancer or precancerous lesions using a scope. The AI analyzes live images during the procedure and overlays a suggested cutting path on the screen. Half of the participants will have the standard procedure, while the other half will use the AI guidance. The study measures whether the AI reduces surgery time and doctor fatigue, and whether it lowers risks like bleeding or damage to the esophageal wall.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
AI-based Dissection Trajectory Prediction System (ADTPS), a software that overlays a recommended cutting path on endoscopic images during surgery
What this could lead to
If it works, this AI guidance could make endoscopic removal of early esophageal cancer quicker, less tiring for surgeons, and possibly reduce complications like bleeding or perforation.
What could go wrong
This is a single-center trial with 160 patients, so results may not apply broadly. The AI only offers visual guidance, and its benefit over standard care is unproven; there is also a risk of technical failures or inaccurate predictions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AI-BASED DISSECTION TRAJECTORY PREDICTION SYSTEM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.